13-Aug-15, Reuters
Shanghai-listed Jangho said it plans to buy Vision Eye Institute for AUD1.10 a share, a 20 percent premium to its last closing price, and that Vision’s board plans to accept the all-cash, off-market offer.
Embassy%20of%20PRC.jpg "China eye surgery (c)Embassy of PRC")
Image: Embassy of PRC
Australia’s health care sector is seen as a lucrative investment given the country’s rapidly aging population and generous government subsidies.
Jangho said it also plans to use its investment to bring Australian health care skills to the mainland, which plans to double its doctor count by 2020.